These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

354 related items for PubMed ID: 14580096

  • 1. Detection and characterization of focal liver lesions using superparamagnetic iron oxide-enhanced magnetic resonance imaging: comparison between ferumoxides-enhanced T1-weighted imaging and delayed-phase gadolinium-enhanced T1-weighted imaging.
    Takahama K, Amano Y, Hayashi H, Ishihara M, Kumazaki T.
    Abdom Imaging; 2003; 28(4):525-30. PubMed ID: 14580096
    [Abstract] [Full Text] [Related]

  • 2. Characterization of focal liver lesions with superparamagnetic iron oxide-enhanced MR imaging: value of distributional phase T1-weighted imaging.
    Lee JM, Kim CS, Youk JH, Lee MS.
    Korean J Radiol; 2003; 4(1):9-18. PubMed ID: 12679629
    [Abstract] [Full Text] [Related]

  • 3. Magnetic resonance imaging of focal liver lesions. Comparison of the superparamagnetic iron oxide resovist versus gadolinium-DTPA in the same patient.
    Vogl TJ, Hammerstingl R, Schwarz W, Kümmel S, Müller PK, Balzer T, Lauten MJ, Balzer JO, Mack MG, Schimpfky C, Schrem H, Bechstein WO, Neuhaus P, Felix R.
    Invest Radiol; 1996 Nov; 31(11):696-708. PubMed ID: 8915751
    [Abstract] [Full Text] [Related]

  • 4. Hepatocellular carcinoma: detection with gadolinium- and ferumoxides-enhanced MR imaging of the liver.
    Pauleit D, Textor J, Bachmann R, Conrad R, Flacke S, Layer G, Kreft B, Schild H.
    Radiology; 2002 Jan; 222(1):73-80. PubMed ID: 11756708
    [Abstract] [Full Text] [Related]

  • 5. Characterization of focal hepatic lesions with ferumoxides-enhanced MR imaging: utility of T1-weighted spoiled gradient recalled echo images using different echo times.
    Kim JH, Kim MJ, Suh SH, Chung JJ, Yoo HS, Lee JT.
    J Magn Reson Imaging; 2002 May; 15(5):573-83. PubMed ID: 11997899
    [Abstract] [Full Text] [Related]

  • 6. Detection of hepatocellular carcinoma arising in cirrhotic livers: comparison of gadolinium- and ferumoxides-enhanced MR imaging.
    Tang Y, Yamashita Y, Arakawa A, Namimoto T, Mitsuzaki K, Abe Y, Katahira K, Takahashi M.
    AJR Am J Roentgenol; 1999 Jun; 172(6):1547-54. PubMed ID: 10350287
    [Abstract] [Full Text] [Related]

  • 7. Nodule-in-nodule appearance of hepatocellular carcinomas: comparison of gadolinium-enhanced and ferumoxides-enhanced magnetic resonance imaging.
    Goshima S, Kanematsu M, Matsuo M, Kondo H, Kato H, Yokoyama R, Hoshi H, Moriyama N.
    J Magn Reson Imaging; 2004 Aug; 20(2):250-5. PubMed ID: 15269950
    [Abstract] [Full Text] [Related]

  • 8. Detection of liver metastases: comparison of gadobenate dimeglumine-enhanced and ferumoxides-enhanced MR imaging examinations.
    del Frate C, Bazzocchi M, Mortele KJ, Zuiani C, Londero V, Como G, Zanardi R, Ros PR.
    Radiology; 2002 Dec; 225(3):766-72. PubMed ID: 12461259
    [Abstract] [Full Text] [Related]

  • 9. Comparison of dynamic gadolinium-enhanced and ferumoxides-enhanced MRI of the liver on high- and low-field scanners.
    Limanond P, Raman SS, Sayre J, Lu DS.
    J Magn Reson Imaging; 2004 Oct; 20(4):640-7. PubMed ID: 15390231
    [Abstract] [Full Text] [Related]

  • 10. [Magnetic resonance imaging of hepatic focal lesions: dynamic contrastographic evaluation with gadolinium versus reticulo-endothelial hepato-specific contrast media].
    Di Cesare E, Cariello G, Barile A, Sabatini M, Michelini O, Erriquez D, Masciocchi C.
    Radiol Med; 2000 Oct; 100(4):245-50. PubMed ID: 11155451
    [Abstract] [Full Text] [Related]

  • 11. Hepatic metastases: diffusion-weighted sensitivity-encoding versus SPIO-enhanced MR imaging.
    Nasu K, Kuroki Y, Nawano S, Kuroki S, Tsukamoto T, Yamamoto S, Motoori K, Ueda T.
    Radiology; 2006 Apr; 239(1):122-30. PubMed ID: 16493012
    [Abstract] [Full Text] [Related]

  • 12. Detection and characterization of focal liver lesions: a Japanese phase III, multicenter comparison between gadoxetic acid disodium-enhanced magnetic resonance imaging and contrast-enhanced computed tomography predominantly in patients with hepatocellular carcinoma and chronic liver disease.
    Ichikawa T, Saito K, Yoshioka N, Tanimoto A, Gokan T, Takehara Y, Kamura T, Gabata T, Murakami T, Ito K, Hirohashi S, Nishie A, Saito Y, Onaya H, Kuwatsuru R, Morimoto A, Ueda K, Kurauchi M, Breuer J.
    Invest Radiol; 2010 Mar; 45(3):133-41. PubMed ID: 20098330
    [Abstract] [Full Text] [Related]

  • 13. Blood-pool MR contrast material for detection and characterization of focal hepatic lesions: initial clinical experience with ultrasmall superparamagnetic iron oxide (AMI-227).
    Saini S, Edelman RR, Sharma P, Li W, Mayo-Smith W, Slater GJ, Eisenberg PJ, Hahn PF.
    AJR Am J Roentgenol; 1995 May; 164(5):1147-52. PubMed ID: 7717222
    [Abstract] [Full Text] [Related]

  • 14. Hepatocellular carcinoma in cirrhosis: enhancement patterns at dynamic gadolinium- and superparamagnetic iron oxide-enhanced T1-weighted MR imaging.
    Lutz AM, Willmann JK, Goepfert K, Marincek B, Weishaupt D.
    Radiology; 2005 Nov; 237(2):520-8. PubMed ID: 16192317
    [Abstract] [Full Text] [Related]

  • 15. Detection of hepatocellular carcinoma: comparison of Gd-DTPA- and ferumoxides-enhanced MR imaging.
    Simon G, Link TM, Wörtler K, Doebereiner F, Schulte-Frohlinde E, Daldrup-Link H, Settles M, Rummeny EJ.
    Eur Radiol; 2005 May; 15(5):895-903. PubMed ID: 15800773
    [Abstract] [Full Text] [Related]

  • 16. Detection of hepatocellular carcinoma by ferumoxides-enhanced MR imaging in cirrhosis: Incremental value of dynamic gadolinium-enhancement.
    Qayyum A, Thoeni RF, Coakley FV, Lu Y, Guay JP, Ferrell LD.
    J Magn Reson Imaging; 2006 Jan; 23(1):17-22. PubMed ID: 16315209
    [Abstract] [Full Text] [Related]

  • 17. MR imaging with i.v. superparamagnetic iron oxide: efficacy in the detection of focal hepatic lesions.
    Winter TC, Freeny PC, Nghiem HV, Mack LA, Patten RM, Thomas CR, Elliott S.
    AJR Am J Roentgenol; 1993 Dec; 161(6):1191-8. PubMed ID: 8249724
    [Abstract] [Full Text] [Related]

  • 18. Ferumoxides-enhanced double-echo T2-weighted MR imaging in differentiating metastases from nonsolid benign lesions of the liver.
    Arbab AS, Ichikawa T, Sou H, Araki T, Nakajima H, Ishigame K, Yoshikawa T, Kumagai H.
    Radiology; 2002 Oct; 225(1):151-8. PubMed ID: 12354999
    [Abstract] [Full Text] [Related]

  • 19. Characterization of focal hepatic lesions with ferumoxides-enhanced T2-weighted MR imaging.
    Paley MR, Mergo PJ, Torres GM, Ros PR.
    AJR Am J Roentgenol; 2000 Jul; 175(1):159-63. PubMed ID: 10882267
    [Abstract] [Full Text] [Related]

  • 20. [Use of SPIO-enhanced T1- and T2-weighted images for the differentiation of liver lesions: an ROC analysis].
    Stroszczynski C, Gaffke G, Gretschel S, Rambow A, Jost D, Schlecht I, Schneider U, Schicke B, Hohenberger P, Gebauer B, Felix R.
    Rofo; 2003 Oct; 175(10):1368-75. PubMed ID: 14556106
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.